Bacteremia in febrile nonneutropenic pediatric oncology patients

Pediatric Blood and Cancer

Volumn 54, Issue 1, 2010, Pages 83-87

  Kelly, Michael J ^a   Vivier, Patrick M ^b   Panken, Tali M ^a   Schwartz, Cindy L ^a  

^a HASBRO CHILDREN'S HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Bacteremia; Catheter; Nonneutropenia; Oncology; Pediatrics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CLINDAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER LWOFFII; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS; BACTEREMIA; BACTERIAL INFECTION; BRAIN TUMOR; CANCER PATIENT; CENTRAL VENOUS CATHETER; CHILD; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEUROBLASTOMA; NEUTROPHIL COUNT; OUTPATIENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS PUTIDA; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SOLID TUMOR; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; BACTERIUM; DRUG EFFECT; MICROBIOLOGY; NEOPLASM; NEUTROPHIL; NEWBORN; PATHOGENICITY;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FEVER; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; NEUTROPHILS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 73349107163     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22264     Document Type: Article

References (22)

1. Schwartz J, Griffin G, Wiltrout A, et al. Effect of neutrophil count and central venous access device on bacteremia in febrile pediatric oncology patients. Pediatr Blood Cancer 2007;48:622.
2. Reilly A, Spandorfer P, Alessandrini E, et al. Outpatient therapy for fever and a central venous catheter in children with cancer. Pediatr Blood Cancer 2007;48:622.
3. Mueller BU, Skelton J, Callender DP, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;10:1943-1948.
4. McLean TW, Fisher CJ, Snively BM, et al. Central venous lines in children with lesser risk acute lymphoblastic leukemia: Optimal type and timing of placement. J Clin Oncol 2005;23:3024-3029.
5. HughesWT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-751.
6. Gorelick MH, Owen WC, Seibel NL, et al. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients. Pediatr Infect Dis 1991;10:506-510.
7. Allen RC, Holdsworth MT, Johnson CA, et al. Risk determinants for catheter-associated blood stream infections in children and young adults with cancer. Pediatr Blood Cancer 2008;51:53-58.
8. Pizzo PA, Robichaud KJ,Wesley R, et al. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 1982;61:153-165.
9. Wurzel CL, Halom K, Feldman JG, et al. Infection rates of Broviac-Hickman catheters and implantable venous devices.AmJ Dis Child 1988;142:536-540.
10. Mirro J, Jr., Rao BN, Stokes DC, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214-222.
11. Ingram J, Weitzman S, Greenberg ML, et al. Complications of indwelling venous access lines in the pediatric hematology patient: A prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-136.
12. Hiemenz J, Skelton J, Pizzo PA. Perspective on the management of catheter-related infections in cancer patients. Pediatr Infect Dis J 1986;5:6-11.
13. Hartman GE, Shochat SJ. Management of septic complications associated with Silastic catheters in childhood malignancy. Pediatr Infect Dis J 1987;6:1042-1047.
14. Walsh T, Roilides E, Groll A, et al. Infectious complications in pediatric cancer patients. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology, 5th edition. Philadelphia: Lippincott; 2006.
15. Mermel LA, Farr BM, Sheretz RJ, et al. Guidelines for the management of catheter-related infections. Clin Infect Dis 2001; 32:1249-1272.
16. Overturf GD. Technical report: Prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis. Pediatrics 2000;106:367-376.
17. Reilly AF, Lange BL. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer 2007;49:774-780.
18. Rackoff WR, Gonin R, Robinson C, et al. Predicting the risk of bacteremia in children with fever and neutropenia. J Clin Oncol 1996;14:919-924.
19. Klaassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 2000;18:1012-1019.
20. Adler A, Yaniv I, Steinberg R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect 2006;62:358-365.
21. Greenes DS, Harper MB. Lowrisk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999;18: 258-261.
22. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51:1-29.